U.S. FDA Approves Agios AQVESME (mitapivat) for the Treatment of Anemia in Adults with Alpha- or Beta-Thalassemia
AQVESME is the only FDA-approved medicine for anemia in both non-transfusion-dependent and…
Cellectar Biosciences Announces Strategic Supply Agreement with Ionetix for Actinium-225 and Astatine-211 to Advance Targeted Alpha Therapies
Supports Development of Phospholipid Radioconjugate (PRC) CLR-225 for the Treatment of Solid…
Alpha Tau Successfully Treats First Patient in its U.S. Trial for Patients with Recurrent Glioblastoma at the James Cancer Hospital at The Ohio State University
- First patient in the world treated with Alpha DaRT® in the…
KuCoin Launches KuCoin Alpha: Enriching the Ecosystem with Seamless On-Chain Innovation
PROVIDENCIALES, Turks and Caicos Islands, Dec. 1, 2025 /PRNewswire/ -- KuCoin, a…
First Among CEXs: Bybit Alpha Launches Liquidity Farm, Unlocking Access to DeFi Yield
DUBAI, UAE, Nov. 28, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange…
TermMax Alpha Launches on BNB Chain: Trade Binance Alpha Tokens with Leverage, Zero Liquidations
HONG KONG, Nov. 12, 2025 /PRNewswire/ -- Term Structure Labs, backed by…
Bybit Alpha Referral Program Now Live: Up to 30% in Trading Fee Rewards
DUBAI, United Arab Emirates, Nov. 7, 2025 /PRNewswire/ -- Bybit, the world's second-largest…
Bybit Alpha Celebrates Luck and Mastery with up to 8,000 USDT in Rewards for Top Winners
DUBAI, UAE, Oct. 30, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by…
Bybit Web3 Transforms into Bybit Alpha, A One-Click Smart Gateway to On-Chain Opportunities
DUBAI, UAE, Oct. 20, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency…
Press Release: ESMO: AlphaMedixTM phase 2 data support first-in-class potential of new targeted alpha therapy in gastroenteropancreatic neuroendocrine tumors
ESMO: AlphaMedixTM phase 2 data support first-in-class potential of new targeted alpha…
